Chemical inhibitors of SOBP can impede its function through various molecular interactions that affect the signaling pathways integral to SOBP's role in the cell. Staurosporine acts by inhibiting protein kinase C, which is upstream of SOBP; this interruption in signaling can diminish SOBP's participation in neuronal differentiation. Similarly, LY294002 targets PI3K, a kinase that can regulate the subcellular localization of SOBP, which is crucial for its transcriptional regulatory functions. The inhibition of PI3K by LY294002, therefore, can lead to a decrease in SOBP activity. U0126 targets MEK1/2, preventing the activation of ERK1/2 signaling, which is necessary for SOBP's involvement in neural development. SB203580 and SP600125 inhibit p38 MAP kinase and JNK, respectively; both kinases potentially phosphorylate SOBP, thereby influencing its activity in transcriptional regulation and DNA damage response. By impeding these kinases, SB203580 and SP600125 can reduce SOBP's functional engagement in these critical cellular processes.
Wortmannin, another PI3K inhibitor like LY294002, can disrupt signaling pathways that affect SOBP's gene regulation related to synaptic plasticity. Rapamycin acts on mTOR, a pathway component that impacts SOBP's role in neuronal differentiation and plasticity; inhibition by rapamycin can limit the protein's functional activity. PD98059, an MEK inhibitor, can decrease ERK pathway signaling, thereby reducing SOBP's influence on neuronal development. PP2 targets Src family kinases and can alter the signaling pathways that dictate SOBP's activity in neurodevelopment. Y-27632 inhibits ROCK, potentially affecting cytoskeletal dynamics with which SOBP is implicated, thus inhibiting its role in cell structure regulation. Finally, Gefitinib and Lapatinib, which target EGFR tyrosine kinase and HER2/EGFR, respectively, can disrupt downstream signaling pathways, which play a part in regulating SOBP's function in synaptic formation and plasticity. Through these diverse mechanisms, each chemical can contribute to the functional inhibition of SOBP by targeting specific signaling pathways and cellular processes.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinase C, a pathway component upstream of SOBP, leading to the inhibition of SOBP's role in neuronal differentiation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, which is involved in the regulation of SOBP's subcellular localization, thus inhibiting SOBP's function in transcriptional regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2, thus preventing the activation of ERK1/2 signaling that may be required for the proper function of SOBP in neural development. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which may impact the phosphorylation state and activity of SOBP, inhibiting its role in transcriptional regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which could alter the phosphorylation state of SOBP, leading to inhibition of its function in DNA damage response. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor that would inhibit the signaling pathways influencing SOBP's activity in the regulation of gene expression related to synaptic plasticity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the signaling pathway that influences SOBP's function in neuronal differentiation and plasticity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK, which would inhibit ERK pathway signaling, thereby inhibiting SOBP's function in neuronal development. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is an Src family kinase inhibitor, which could inhibit signaling pathways that regulate SOBP's activity in neurodevelopmental processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 inhibits ROCK, which could alter the cytoskeletal dynamics that SOBP is implicated in, thus inhibiting its role in cell structure regulation. | ||||||